J Infect Dis. 2009 Mar 1;199(5):711-6.

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.

Karron RA, Callahan K, Luke C, Thumar B, McAuliffe J, Schappell E, Joseph T, Coelingh K, Jin H, Kemble G, Murphy BR, Subbarao K.

Source

Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA. rkarron@jhsph.edu

Abstract

Development of live attenuated influenza vaccines (LAIV) against avian strains with pandemic potential is an important public-health strategy. Either 1 or 2 10(7)-TCID(50) doses of H9N2 LAIV A/chicken/Hong Kong/G9/97 were administered intranasally to 50 adults in isolation; 41 participants were H9N2 seronegative, 24 of whom received 2 doses. The vaccine was well tolerated; vaccine shedding was minimal. After 2 doses, 92% of H9-seronegative participants had > or = 4-fold increases in hemagglutination-inhibition antibody, and 79% had > or = 4-fold increases in neutralizing antibody; 100% had responses detected by at least 1 assay. Although replication of the H9N2 LAIV was restricted, 2 doses were immunogenic in H9N2-seronegative adults. Trial registration. ClinicalTrials.gov identifier: NCT00110279 .

PMID:: 19210163; [PubMed - indexed for MEDLINE]
PMCID:: PMC2804070

Free PMC Article

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. [Vaccine. 2009]
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, et al. Vaccine. 2009 Jun 8; 27(28):3744-53. Epub 2009 Apr 17.
Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. [Vaccine. 2009]
Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.
Karron RA, Talaat K, Luke C, Callahan K, Thumar B, Dilorenzo S, McAuliffe J, Schappell E, Suguitan A, Mills K, et al. Vaccine. 2009 Aug 6; 27(36):4953-60. Epub 2009 Jun 21.
Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations. [Vaccine. 2009]
Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations.
Nicholson KG, Thompson CI, Klap JM, Wood JM, Batham S, Newman RW, Mischler R, Zambon MC, Stephenson I. Vaccine. 2009 Dec 10; 28(1):171-8. Epub 2009 Sep 30.
Review Live attenuated vaccines for pandemic influenza. [Curr Top Microbiol Immunol. 2009]
Review Live attenuated vaccines for pandemic influenza.
Chen GL, Subbarao K. Curr Top Microbiol Immunol. 2009; 333:109-32.
Review Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. [Influenza Other Respi Viruses....]
Review Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.
Ambrose CS, Luke C, Coelingh K. Influenza Other Respi Viruses. 2008 Nov; 2(6):193-202.

See reviews... See all...

Cited by 8 PubMed Central articles

Developing vaccines to combat pandemic influenza. [Viruses. 2010]
Developing vaccines to combat pandemic influenza.
Robertson JS, Engelhardt OG. Viruses. 2010 Feb; 2(2):532-46. Epub 2010 Feb 2.
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. [Vaccine. 2011]
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.
Talaat KR, Karron RA, Luke CJ, Thumar B, McMahon BA, Chen GL, Lamirande EW, Jin H, Coelingh KL, Kemble G, et al. Vaccine. 2011 Apr 12; 29(17):3144-8. Epub 2011 Mar 4.
Label-free, arrayed sensing of immune response to influenza antigens. [Talanta. 2011]
Label-free, arrayed sensing of immune response to influenza antigens.
Mace CR, Topham DJ, Mosmann TR, Quataert SA, Treanor JJ, Miller BL. Talanta. 2011 Jan 15; 83(3):1000-5. Epub 2010 Nov 10.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in he...
A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.
J Infect Dis. 2009 Mar 1 ;199(5):711-6.

PubMed
Escitalopram in the treatment of major depressive disorder: a meta-analysis.
Escitalopram in the treatment of major depressive disorder: a meta-analysis.
Curr Med Res Opin. 2009 Jan ;25(1):161-75.

PubMed
Limitations of statin monotherapy for the treatment of dyslipidemia: a projectio...
Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study--observational.
Curr Med Res Opin. 2009 Jan ;25(1):47-55.

PubMed
Protein profile analysis of the breast microenvironment to differentiate healthy...
Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients.
Expert Rev Proteomics. 2009 Feb ;6(1):43-60.

PubMed
Johns Hopkins course: 8th annual Current Topics in Gastrointestinal and Liver Pa...
Johns Hopkins course: 8th annual Current Topics in Gastrointestinal and Liver Pathology.
Expert Rev Gastroenterol Hepatol. 2009 Feb ;3(1):33-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.

Source

Abstract

Publication Types, MeSH Terms, Substances, Secondary Source ID, Grant Support

Publication Types

MeSH Terms

Substances

Secondary Source ID

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 8 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information